← All organizations
Highest phase reached
Phase 2
First clinical trial
May 31, 2023Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (11)
- NCT07131345OfficialPhase 1/Phase 2Sep 1, 2025
- NCT07131345Lead sponsorPhase 1/Phase 2Sep 1, 2025
- NCT07131345Sponsor investigatorPhase 1/Phase 2Sep 1, 2025
- NCT06827145Lead sponsorPhase 2Oct 14, 2024
- NCT06414915Sponsor investigatorPhase 2Jun 1, 2024
- NCT06414915Lead sponsorPhase 2Jun 1, 2024
- NCT06362980Sponsor investigatorPhase 1May 22, 2024
- NCT06362980Lead sponsorPhase 1May 22, 2024
- NCT05830890Lead sponsorN/AMay 31, 2023
- NCT05830890Study chairN/AMay 31, 2023
- NCT05830890Reponsible party - principal investigatorN/AMay 31, 2023
Details
- Last known activity
- Sep 1, 2025